Rudolph and Sletten, a subsidiary of Tutor Perini, has been awarded a contract exceeding $1 billion for a major healthcare campus project in California 🇺🇸. The expansive development will include a new hospital, an energy center, and a parking garage, with construction slated to begin in late 2024 and substantial completion anticipated by 2029 🔨🚧.

This project contributes to Tutor Perini's record-breaking backlog, which stood at approximately $14 billion as of September 30, 2024, marking a 35% increase from earlier this year 📈.

At the Global Health Exhibition in Riyadh, Saudi Arabia’s Health Minister Fahad Al Jalajel revealed $13.3 billion in new healthcare investments, focusing on expanding healthcare infrastructure and strategic partnerships.

🔹 $1 Billion Partnership: NUPCO, Novo Nordisk, and Sanofi to boost pharmaceutical manufacturing.

🔹 $1.3 Billion Expansion: Fakeeh Care Group enhancing healthcare capacity.

🔹 $798 Million by Almoosa Health Group: Five primary care centers and two new hospitals.

🔹 Dallah Health’s Acquisitions: Al Salam and Al Ahsa hospitals, adding 749 beds, plus a $1 billion, 250-bed hospital planned in Riyadh.

The exhibition also introduced partnerships among universities, healthcare institutions, and the private sector to drive innovation and workforce development. These investments mark a major step in Saudi Arabia’s mission to strengthen its healthcare sector and meet rising demand. 🌍👩‍⚕️🩺

Select Medical Corporation has announced plans to operate a new state-of-the-art inpatient rehabilitation hospital in Temple, Texas. The facility will feature over 40 beds and span 48,000 square feet, scheduled to open in late Q1 2025.

Tom Mullin, president of Select Medical, emphasized the growing need for inpatient rehabilitation services in Texas, highlighting the hospital's role in providing access to care for patients recovering from conditions such as stroke, traumatic brain injuries, and spinal cord injuries across Central Texas. With this new addition, Texas will become one of Select Medical's largest markets, offering a comprehensive continuum of post-acute care.

The new hospital will complement Select Medical's existing operations in the region, which include four inpatient rehabilitation hospitals in the Dallas-Fort Worth area and various outpatient physical therapy centers, established through a joint venture with Baylor Scott & White Health.

Select Medical is a leading operator of critical illness recovery hospitals and rehabilitation facilities in the U.S., with operations spanning 46 states and the District of Columbia.

GE HealthCare (GEHC) has announced a partnership with University Medicine Essen to create a new Theranostics Center of Excellence in Germany. This center aims to enhance the use of theranostics in clinical settings and promote research focused on personalized cancer care 🎗️.

As part of this initiative, GEHC will supply essential equipment for the university's new radiotracer development center, including a cyclotron ⚛️, synthesizer, and laboratory facilities 🧪. The installation will feature advanced imaging systems, such as the Omni Legend 32cm PET/CT scanner 📸, SIGNA PET/MR scanner, and various SPECT/CT systems, equipped with AI software to improve image acquisition and analytics through MIM Software’s suite 📊.

Additionally, GE HealthCare is working with nuclear medicine specialists at the university to develop a new total-body PET/CT scanner 🏥, further advancing the capabilities of cancer diagnostics and treatment.

UK-based medical device company CMR Surgical has received clearance from the U.S. Food and Drug Administration (FDA) for the upgraded version of its Versius Surgical System to assist in gallbladder removal procedures. The robotic device, which is portable, is approved for patients aged 22 and older who qualify for minimally invasive surgery 🏥🔧.

This marks a major milestone for CMR Surgical, which aims to fill a market gap with its innovative system. While the company has not disclosed details about commercialization or pricing for the U.S. market, it expects the cost to be "favorable" 💲. Initially, CMR plans to partner with a few U.S. hospitals before gradually expanding its reach nationwide 🏨.

The Versius device was cleared through the FDA's De Novo application process, a pathway reserved for novel medical devices that lack a legally marketed equivalent in the U.S. Prior to this, the system had already secured its CE mark in Europe in 2019 🇪🇺.